Texas Border Business
By Maria Gonzalez / UTRGV
RIO GRANDE VALLEY, Texas – The University of Texas Rio Grande Valley has received a $2.8 million grant from the Cancer Prevention and Research Institute of Texas (CPRIT) to launch the Drug Delivery and Nanomedicine Core (DDNC), a specialized research facility focused on advancing cancer research, education and care through nanotechnology.
The new core, which began operations June 1, is located within the university’s South Texas Center of Excellence in Cancer Research (ST-CECR) in McAllen. It is the first facility of its kind within a 250-mile radius and does not duplicate any other existing core facility in Texas.
“This facility will directly address one of the greatest health needs of our region – cancer,” said Dr. Can Saygin, UTRGV senior vice president for research and dean of the Graduate College. “It will bring advanced resources and clinical partnerships to the Valley, strengthen our research capacity and give our faculty and students access to groundbreaking tools in drug delivery and nanomedicine.”
Read the full story at:
